EGFR and neoplasm: For instance, there is a need to explore how AhR knockdown or pharmacological inhibition would affect PM2.5 induced tumor promotion in lung AT2 cells with EGFR driver mutations and to compare the impact of PM2.5 with high or low PAH content on these responses.